Some Countries Suspended AstraZeneca's COVID Vaccine. Here's What Investors Need to Know.
It's fair to say AstraZeneca (NASDAQ: AZN) is a major player in the coronavirus vaccine market. More than 50 countries have authorized its vaccine. But in recent weeks, woes have been multiplying. First came reports of low efficacy against the South African strain. Even worse, in recent days several European countries suspended use of the vaccine over safety concerts.
Meanwhile, AstraZeneca is collecting data from its phase 3 U.S. trial -- a clinical trial report and request for Emergency Use Authorization (EUA) in the U.S. should soon follow. Now, you may be wondering about the vaccine's chances in the U.S. market -- and if its problems in Europe will ease. And what will all of this mean for the stock? Here's what you need to know.
Source Fool.com